Northrop Grumman executive Thomas H. Jones, CVP & President Aeronautics Systems, reported equity compensation activity. He received 5,927.1200 Restricted Performance Stock Rights and 1,701.0000 Restricted Stock Rights, and settled 6,910.1200 performance-based units into common stock, with 3,059.0000 shares withheld at $678.8300 per share for taxes. Following these transactions he holds 14,174 Restricted Performance Stock Rights and 10,057.715 shares of common stock directly.
Northrop Grumman’s corporate vice president and general counsel Kathryn G. Simpson received new stock-based compensation and settled prior awards. On February 11, 2026, she acquired 3,619.96 Restricted Performance Stock Rights (RPSRs) and 1,471 Restricted Stock Rights (RSRs), both granted at an exercise price of $0 under long‑term incentive plans.
She exercised 1,334.96 RPSRs, receiving the same number of common shares at $0, then had 461 shares withheld at $678.83 per share to cover tax obligations, leaving 1,653.39 common shares owned directly. Following these transactions, she directly holds 12,579.96 RPSRs and 5,555 RSRs, which may convert into common stock if performance and time‑based vesting conditions are met.
Warden Kathy J reported multiple insider transaction types in a Form 4 filing for NOC. The filing lists transactions totaling 121,361 shares at a weighted average price of $678.83 per share. Following the reported transactions, holdings were 102,064 shares.
Greene John reported acquisition or exercise transactions in a Form 4 filing for NOC. The filing lists transactions totaling 10,343 shares. Following the reported transactions, holdings were 4,981 shares.
Northrop Grumman executive Benjamin R. Davies reported multiple equity compensation transactions. On February 11, 2026, he was granted 4,710.32 Restricted Performance Stock Rights and 1,701 Restricted Stock Rights, each representing a contingent right to receive an equal number of common shares or, at the company’s election, cash or a mix of stock and cash.
On the same date, 3,158.32 Restricted Performance Stock Rights were exercised, delivering an equal number of common shares at an exercise price of $0. Of those shares, 1,214 common shares were disposed of at $678.83 per share to satisfy tax obligations, leaving 2,189.04 common shares held directly after the reported transactions, plus a small indirect position held in the Northrop Grumman Savings Plan.
Northrop Grumman executive Robert J. Fleming, CVP and President, Space Systems, received equity awards on 2026-02-11, including 3,982.16 Restricted Performance Stock Rights and 1,701 Restricted Stock Rights. He settled 913.16 performance rights into common stock, with 300 shares withheld at $678.83 per share for taxes. After these transactions he holds 14,174 Restricted Performance Stock Rights and 2,440.03 shares of common stock, all directly.
Northrop Grumman executive Roshan S. Roeder, CVP & President of Mission Systems, reported multiple equity compensation transactions dated February 11, 2026. Roeder acquired 5,786.48 Restricted Performance Stock Rights (RPSRs) and 1,701 Restricted Stock Rights (RSRs), both at an exercise price of $0 per right, as part of long-term incentive plans.
On the same date, 6,476.48 RPSRs were exercised into the same number of common shares at $0, increasing direct common stock holdings to 6,880.39 shares before withholding. To cover tax obligations, 2,968 common shares were disposed of at $678.83 per share, leaving 3,912.39 common shares held directly after the transactions, plus 115.5111 shares held indirectly in the Northrop Grumman Savings Plan as of February 11, 2026.
Northrop Grumman insider plans to sell restricted stock that recently vested. A holder has filed a Form 144 notice to sell up to 784 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $550,410.63.
The shares were acquired as compensation through restricted stock vesting, including 203 shares on 02/13/2023 and 581 shares on 02/11/2026. The issuer had 141,921,621 common shares outstanding at the time referenced, providing context for the planned sale size.
Northrop Grumman (NOC) reported an insider sale by Chair, CEO and President Kathy J. Warden on February 6, 2026. She sold a total of 20,000 shares of common stock in multiple transactions at weighted average prices ranging from $705.84 to $711.14, with individual trade price ranges between $705.56 and $711.40. Following these sales, she directly owned 171,602.4 shares of Northrop Grumman common stock.
An insider has filed a notice to sell 20,000 shares of common stock, to be executed through Fidelity Brokerage Services LLC on the NYSE around February 6, 2026. The filing lists an aggregate market value of 14,176,423.20 for these shares, with 141,921,621 shares of the class outstanding.
The shares to be sold were acquired through restricted stock vesting from the issuer on February 13, 2022, February 15, 2022, and February 14, 2024 as compensation. Over the prior three months, the same seller disposed of 7,000 shares of common stock on January 5, 2026 for 4,200,000.00 and a further 3,000 shares on January 6, 2026 for 1,845,000.00.